Pre-earnings brief
Reports
Wed, Nov 11, 2026
Est. EPS
—
Est. revenue
—
Implied move
±8.2%
EPS beat rate
100%
Cellebrite DI Ltd. (CLBT) operates in the Information Technology sector, focusing on application software that helps law enforcement and businesses manage digital investigations. As digital data continues to grow, Cellebrite's solutions are increasingly relevant for security and compliance in various industries.
Last quarter
In Q2 2026, Cellebrite reported an EPS of $0.11, beating expectations by 29.41%. However, the stock fell 29.18% the following day, indicating market concerns despite the positive earnings surprise.
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+49.68%
Avg 1-day reaction
-4.88%
Overall, expectations for Cellebrite's upcoming earnings are uncertain due to the lack of analyst estimates and management guidance. Investors are keen to see if the company can maintain its positive EPS trend.
Bull case
If Cellebrite continues to beat EPS expectations, it could signal strong operational efficiency and demand for its products, leading to a potential rebound in stock price.
Bear case
Conversely, if the company fails to meet expectations or shows signs of declining revenue, it may reinforce negative sentiment and lead to further stock price declines.
The print will turn on these.
Q1
What will be the EPS for Q3-2026?
Given the company's history of beating EPS estimates, this number will be crucial for investor confidence and stock performance.
Q2
How is revenue trending compared to previous quarters?
Revenue growth is essential for assessing the company's market position and future prospects, especially in light of recent stock price volatility.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±11.1%
Why consensus could be wrong
The Street may underestimate the potential for Cellebrite to leverage its technology in new markets, which could drive unexpected revenue growth.
Supporting evidence
Cellebrite has consistently beaten EPS estimates in the past, indicating strong operational performance.
The options market is pricing in a relatively modest move compared to historical volatility, suggesting potential upside.
Recent trends in digital security highlight increasing demand for Cellebrite's solutions, which may not be fully reflected in current expectations.
Key risk
If revenue growth shows signs of acceleration, it could challenge the current cautious outlook.
Pre-commit to what would confirm each case.
The core debate this quarter revolves around whether Cellebrite can sustain its earnings momentum amidst market pressures.
Bull confirmed if
An EPS of $0.12 or higher would confirm the bull case and suggest continued profitability.
Bear confirmed if
An EPS below $0.09 would likely confirm the bear case and raise concerns about the company's financial health.
What the market is pricing for the move.
Implied Move
±8.16%
Historical Avg
±9.7%
The options market is pricing in an 8.16% move, suggesting that traders expect significant volatility around the earnings report.
Options are pricing ±8.2% while CLBT has averaged ±9.7% over the last 8 prints — setup is pricing cheap.
ATM IV
0.6%
30d HV
38.5%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Cellebrite beats expectations, history suggests the stock could see an average one-day move of +8.43%, confirming positive market sentiment.
In line / cautious
If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.
Miss
If the company misses expectations, history suggests a potential average one-day decline of -4.88%, which could further dampen investor sentiment.
The lines on the call that would change the story.